Kein Folientitel - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Kein Folientitel

Description:

First report of HBV infection and transmission based exclusively on genotype G (2003 in Germany) ... Investigation of 106 chronic carriers tested positive for ... – PowerPoint PPT presentation

Number of Views:89
Avg rating:3.0/5.0
Slides: 16
Provided by: chu123
Category:

less

Transcript and Presenter's Notes

Title: Kein Folientitel


1
Correlation of HBsAg and HBV DNA Michael Chudy,
Paul-Ehrlich-Institut SoGAT XVIII, Bethesda
MD 24-25 May 2005
2
HBsAg and HBV DNA
  • Most sensitive HBsAg assay detects0.01 ng/ml
    (PEI HBsAg standard ad)
  • HBsAg cut-off correspond to HBV DNA
  • 114 IU/ml (WHO DNA standard)
  • 461 copies/ml (five SC panels ZeptoMetrix)

Good correlation to published data from Biswas et
al. Transfusion 43788-798 (2003)
3
Virus and HBsAg Particles
4
HBsAg reactive polypeptides
  • Most sensitive ELISA detects 10 pg HBsAg/ml
  • Virion-HBsAg
  • One HBV particle 20 ag HBsAg
  • 10 pg HBsAg correspond to about 500,000 HBV
    particles
  • 500 particles/ml (HBsAg cutoff of SC panels) vs.
    500,000 HBV particles/ml
  • Viral surface antigen reactive polypeptides
  • Virion envelope
  • Incomplete viral forms
  • Excessive incomplete viral forms are present
    (about 11,000)
  • Average numbers of molecules of LHBs,
    MHBs, and SHBs 30, 30, and 350, respectively
    Calculation correlate well with data presented by
    Prof. Gerlich (EPFA meeting 2002)

5
Correlation of HBsAg and HBV DNA
  • Is that true for all geno-/subtypes, stages of
    HBV infection?
  • Can HBV NAT replace the HBsAg testing in blood
    donors?

6
HBsAg and HBV DNA
  • HBV DNA reverse transcription from 3.35 kb
    pre-genomic mRNA
  • HBsAg forms translated from
  • LHBs 2.4 kb mRNA
  • MHBs/SHBs 2.1 kb mRNA
  • Level of regulation
  • Transcription
  • Post-transcription
  • e.g. Transport of unspliced mRNAs from nucleus to
    cytoplasm
  • Cellular factors

7
Ratio of total HBsAg to Virion-HBsAgat different
HBV stages
  • Early period of HBV infection
  • Genotype A
  • Genotype G
  • Chronic HBV infection

8
Total HBsAg/Virion-HBsAg ratio in samples of SC
panel PHM911 (BBI)
21 d
data performed in 1995
9
HBV genotype G
  • Only few infections are known (all co-infections
    with genotype A)
  • First report of HBV infection and transmission
    based exclusively on genotype G (2003 in Germany)
  • No escape variant (subtype adw2)
  • HBeg minus variant

Studies were performed in cooperation with the
Institute of Transfusion Medicine and
Immunohematology, GRC, JW Goethe University,
Frankfurt (WK Roth and co-workers)
10
HBV transmission exclusively by genotype G-virus
11
Virion-HBsAg/total HBsAg ratio in genotype G
  • Sample from R3 (2003-09-23) with about 9 Mio
    cps/ml (positive for HBsAg, negative for
    anti-HBc, HBeAg/anti-HBe)
  • Titration in Prism HBsAg test
  • Virus concentration at HBsAg cut-off24,000
    copies/ml
  • Ratio of virion-HBsAg to total HBsAg of 120
  • vs. 11,000 and more in genotype A samples of
    early HBV infection
  • Significant decrease of excessive HBsAg in
    infection with genotype G

12
HBsAg and HBV DNA in chronic HBV infection
  • Lack of correlation between HBsAg and HBV DNA in
    HBsAg/anti-HBc positive tested samples (Kuhns et
    al. 2004, Transfusion 44,1332-1339)

13
HBsAg and HBV DNA in chronic HBV carriers
  • Investigation of 106 chronic carriers tested
    positive for HBsAg, anti-HBc, and anti-HBe
  • Only 84 (89/106) HBV NAT reactive with the
    Procleix Ultrio Assay (Gen-Probe)
  • s/co gt20 5x
  • s/co 15-20 65x
  • s/co 10-15 9x
  • s/co 5-10 7x
  • s/co lt5 3x
  • No correlation to s/co values of HBsAg test
    (Prism)

14
17 HBsAg positive/HBV DNA negative samples of
chronic HBV carriers
15
Summary Correlation ofHBsAg and HBV DNA
  • Virion-HBsAg of one particle (20 ag) correspond
    to one copy of HBV DNA
  • Significant excess of HBsAg particles in the
    early period of HBV infection (genotype A)
  • Variable ratio of Virion-HBsAg to total HBsAg in
    the course of infection (genotype A)
  • Genotype G infection shows a significant decrease
    in synthesis of incomplete viral forms
  • Lack of correlation between HBsAg and HBV DNA in
    chronic infection
  • HBsAg carrier (integrative phase) can be
    non-reactive by HBV NAT
  • Results indicate caution in any consideration of
    dropping HBsAg screening
Write a Comment
User Comments (0)
About PowerShow.com